Publications by authors named "Iliyan Iliev"

The gut mycobiota is crucial for intestinal homeostasis and immune function. Yet its variability and inconsistent fungal colonization of laboratory mice hinders the study of the evolutionary and immune processes that underpin commensalism. Here, we show that Kazachstania pintolopesii is a fungal commensal in wild urban and rural mice, with an exceptional ability to colonize the mouse gastrointestinal tract and dominate the gut mycobiome.

View Article and Find Full Text PDF

Various bacteria are suggested to contribute to colorectal cancer (CRC) development, including pks Escherichia coli, which produces the genotoxin colibactin that induces characteristic mutational signatures in host epithelial cells. However, it remains unclear how the highly unstable colibactin molecule is able to access host epithelial cells to cause harm. Here, using the microbiota-dependent ZEB2-transgenic mouse model of invasive CRC, we demonstrate that the oncogenic potential of pks E.

View Article and Find Full Text PDF

Terrorists and other transnational extremist groups are responsible for thousands of civilian deaths. In confronting extremists, governments have relied heavily on threats, demands, denunciations, and other forms of Do these efforts at verbal coercion have any effect on terrorist behavior? This analysis focuses on the Islamic State in Iraq and Syria (ISIS), which continues to be the world's deadliest terrorist group and was responsible for recent high-profile attacks in Baghdad, Vienna, Kabul, and Russia. We use Bayesian structural vector autoregression models to analyze daily event data on interactions between ISIS and foreign governments for the 2014-2020 period.

View Article and Find Full Text PDF

Fungi play critical roles in the homeostasis of ecosystems globally and have emerged as significant causes of an expanding repertoire of devastating diseases in plants, animals, and humans. In this Commentary, we highlight the importance of fungal pathogens and argue for concerted research efforts to enhance understanding of fungal virulence, antifungal immunity, novel drug targets, antifungal resistance, and the mycobiota to improve human health.

View Article and Find Full Text PDF
Article Synopsis
  • Neutrophil activation needs careful control to prevent diseases, as uncontrolled neutrophil extracellular traps (NETs) can cause more harm than good.
  • A receptor called MICL helps keep this process in check by recognizing DNA in NETs, and when it doesn't work properly, it can lead to too many NETs being formed.
  • In diseases like rheumatoid arthritis and lupus, there are autoantibodies that block MICL, which worsens the disease, but during certain infections, like with a fungus, having more NETs can actually help fight off the infection.
View Article and Find Full Text PDF

The intestine and liver are thought to metabolize dietary nutrients and regulate host nutrient homeostasis. Here, we find that the gut microbiota also reshapes the host amino acid (aa) landscape via efficiently metabolizing intestinal aa. To identify the responsible microbes/genes, we developed a metabolomics-based assay to screen 104 commensals and identified candidates that efficiently utilize aa.

View Article and Find Full Text PDF

Both the gut and the tumour microbiome are now established as crucial regulators of cancer phenotypes and have been implicated in cancer initiation, progression and therapy response. Although the role of bacteria in these processes is beginning to be unravelled, the relevance of fungi is only just emerging. In this Viewpoint, we asked experts to discuss the current knowledge on the mycobiome–cancer connection and share their opinion on how to best solve open questions.

View Article and Find Full Text PDF

Gastrointestinal fungal dysbiosis is a hallmark of several diseases marked by systemic immune activation. Whether persistent pathobiont colonization during immune alterations and impaired gut barrier function has a durable impact on host immunity is unknown. We found that elevated levels of Candida albicans immunoglobulin G (IgG) antibodies marked patients with severe COVID-19 (sCOVID-19) who had intestinal Candida overgrowth, mycobiota dysbiosis and systemic neutrophilia.

View Article and Find Full Text PDF

Aberrant CD4 T cell reactivity against intestinal microorganisms is considered to drive mucosal inflammation in inflammatory bowel diseases. The disease-relevant microbial species and the corresponding microorganism-specific, pathogenic T cell phenotypes remain largely unknown. In the present study, we identified common gut commensal and food-derived yeasts, as direct activators of altered CD4 T cell reactions in patients with Crohn's disease (CD).

View Article and Find Full Text PDF

Various bacteria are suggested to contribute to colorectal cancer (CRC) development, including which produce the genotoxin colibactin that induces characteristic mutational signatures in host epithelial cells. It remains unclear how the highly unstable colibactin molecule is able to access host epithelial cells and its DNA to cause harm. Using the microbiota-dependent ZEB2-transgenic mouse model of invasive CRC, we found that drives CRC exacerbation and tissue invasion in a colibactin-dependent manner.

View Article and Find Full Text PDF

Unlabelled: In some patients with chronic wounds, the surrounding skin is so injured due to various underlying conditions that negative pressure dressing cannot be applied or cannot function properly. Having faced this problem in our everyday practice, we developed a new skin-sparing technique for vacuum-assisted wound closure, which ensures that the peri-wound skin does not come into contact with the transparent adhesive films.

Methods: For 9 months (April-December 2022), we performed 32 vacuum wound dressings with the newly developed technique using the 3M ActiV.

View Article and Find Full Text PDF

Specialized epithelium secretes an antifungal peptide.

View Article and Find Full Text PDF

Recognition of pathogen-associated molecular patterns can trigger the inositol-requiring enzyme 1 α (IRE1α) arm of the endoplasmic reticulum (ER) stress response in innate immune cells. This process maintains ER homeostasis and also coordinates diverse immunomodulatory programs during bacterial and viral infections. However, the role of innate IRE1α signaling in response to fungal pathogens remains elusive.

View Article and Find Full Text PDF

The dynamic and complex community of microbes that colonizes the intestines is composed of bacteria, fungi, and viruses. At the mucosal surfaces, immunoglobulins play a key role in protection against bacterial and fungal pathogens, and their toxins. Secretory immunoglobulin A (sIgA) is the most abundantly produced antibody at the mucosal surfaces, while Immunoglobulin G (IgG) isotypes play a critical role in systemic protection.

View Article and Find Full Text PDF

Microbiota-induced IL-17 production mediates CNS processes and animal behavior. However, its role on the peripheral nervous system (PNS) remains largely unknown. Enamorado et al.

View Article and Find Full Text PDF

Fungal microorganisms (mycobiota) comprise a small but immunoreactive component of the human microbiome, yet little is known about their role in human cancers. Pan-cancer analysis of multiple body sites revealed tumor-associated mycobiomes at up to 1 fungal cell per 10 tumor cells. In lung cancer, Blastomyces was associated with tumor tissues.

View Article and Find Full Text PDF

The fungal kingdom represents an extraordinary diversity of organisms with profound impacts across animal, plant, and ecosystem health. Fungi simultaneously support life, by forming beneficial symbioses with plants and producing life-saving medicines, and bring death, by causing devastating diseases in humans, plants, and animals. With climate change, increased antimicrobial resistance, global trade, environmental degradation, and novel viruses altering the impact of fungi on health and disease, developing new approaches is now more crucial than ever to combat the threats posed by fungi and to harness their extraordinary potential for applications in human health, food supply, and environmental remediation.

View Article and Find Full Text PDF
Article Synopsis
  • The mycobiota, the fungal component of gut microbiota, plays a crucial role in immune regulation and is linked to diseases like inflammatory bowel disease (IBD).
  • Researchers developed a platform to analyze mycobiome functionality at an individual patient level through advanced techniques such as fungal strain editing and immune response assays.
  • They found diverse Candida albicans strains in IBD patients that can trigger inflammation and disease symptoms by damaging immune cells, revealing the importance of strain-specific interactions and offering potential new diagnostic and therapeutic approaches for inflammatory diseases.
View Article and Find Full Text PDF

Fungal communities (the mycobiota) are an integral part of the gut microbiota, and the disruption of their integrity contributes to local and gut-distal pathologies. Yet, the mechanisms by which intestinal fungi promote homeostasis remain unclear. We characterized the mycobiota biogeography along the gastrointestinal tract and identified a subset of fungi associated with the intestinal mucosa of mice and humans.

View Article and Find Full Text PDF

Rationale & Objective: Conventional culture can be insensitive for the detection of rare infections and for the detection of common infections in the setting of recent antibiotic usage. Patients receiving peritoneal dialysis (PD) with suspected peritonitis have a significant proportion of negative conventional cultures. This study examines the utility of metagenomic sequencing of peritoneal effluent cell-free DNA (cfDNA) for evaluating the peritoneal effluent in PD patients with and without peritonitis.

View Article and Find Full Text PDF

Secretory immunoglobulin A (sIgA) plays an important role in gut barrier protection by shaping the resident microbiota community, restricting the growth of bacterial pathogens and enhancing host protective immunity via immunological exclusion. Here, we found that a portion of the microbiota-driven sIgA response is induced by and directed towards intestinal fungi. Analysis of the human gut mycobiota bound by sIgA revealed a preference for hyphae, a fungal morphotype associated with virulence.

View Article and Find Full Text PDF
Article Synopsis
  • Antibodies help protect against viral and bacterial infections, but there are no effective vaccines or antibody treatments for fungal pathogens, which are a significant health concern.
  • Using a new approach called multiKAP, researchers examined human antibodies targeting gut fungi and found that Candida albicans is a major trigger for antifungal antibodies (IgG).
  • The production of these antifungal antibodies requires a specific immune pathway involving the CARD9 gene, and mutations in this gene can lead to reduced antibody responses in individuals suffering from invasive fungal infections like candidiasis.
View Article and Find Full Text PDF